Cited by 48Cholesterol and Lipid MetabolismLipid metabolism and disordersLipoproteins and Cardiovascular Health

Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms

Mikhailenko, Irina, Considine, Wayne, Argraves, Kelley M., Loukinov, Dmitri, Hyman, Bradley T., Strickland, Dudley K.·1999·Journal of Cell Science

Abstract

The very low density lipoprotein (VLDL) receptor is closely related in structure to the low density lipoprotein receptor. The ectodomain of these endocytic receptors is composed of modules which include clusters of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, tyrosine-tryptophan-threonine-aspartic acid (YWTD) repeats and an O-linked sugar domain. To identify important functional regions within the ectodomain of the VLDL receptor, we produced a mutant receptor in which the EGF, YWTD and O-linked sugar domains were deleted. Cells transfected with the mutant receptor were able to bind and internalize (125)I-labeled receptor associated protein (RAP). In contrast to the wild-type receptor, however, RAP did not dissociate from the mutant receptor and consequently was not degraded. Immunofluoresence data indicated that once bound to the mutant receptor, fluorescent-labeled RAP co-localized with markers of the endosomal pathway, whereas, in cells expressing the wild-type receptor, RAP fluorescence co-localized with lysosomal markers. Thus this deleted region is responsible for ligand uncoupling within the endosomes. To identify regions responsible for ligand recognition, soluble receptor fragments containing the eight cysteine-rich class A repeats were produced. (125)I-RAP and (125)I-labeled urokinase-type plasminogen activator:plasminogen activator inhibitor type I (uPA:PAI-1) complexes bound to the soluble fragment with K(D, app) values of 0.3 and 14 n…

Integrity signals

Registry

Crossref · 10.1242/jcs.112.19.3269

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LRAD3 lacks the EGF and β-propeller domains found in extracellular portions of LDL receptor family members.

    “LRAD3 also lacks the EGF and β-propeller domains that are found in the extracellular portions of LDL receptor family members which are important for pH-induced uncoupling of ligands within acidic endosomal compartments (Davis et al., 1987; Mikhailenko et al., 1999; Rudenko et al., 2002).”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 45 · Cited by 48

Authors
Mikhailenko, I., Considine, W., Argraves, K. M., Loukinov, D., Hyman, B. T., & Strickland, D. K.
Affiliations
  • American Red Cross (US)
  • Massachusetts General Hospital (US)
Venue
Journal of Cell Science
Published
1999-10-01
Volume
112
Issue
19
Pages
3269-3281
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W1924359254
Cited by
48
References
45
Citations by year
2022: 1 · 2019: 1 · 2016: 1 · 2015: 1
FWCI
5.26
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cell Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL50784, R01HL050784, P01HL5710)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
VLDLR, LDL receptor, receptor ectodomain, receptor-associated protein, ligand binding, EGF-like repeats, urokinase, plasminogen activator inhibitor-1, allosteric mechanism, receptor internalization, lysosomal degradation, endocytic receptor
MeSH terms
Acids, Allosteric Regulation, Animals, Endocytosis, Epidermal Growth Factor, Fluorescent Antibody Technique, Cricetinae, Humans, Iodine Radioisotopes, Ligands, Peptide Fragments, Protein Binding, Radioligand Assay, Receptors, LDL, Recombinant Fusion Proteins, Transfection, Transferrin, Urokinase-Type Plasminogen Activator, Mutagenesis, CHO Cells, Gene Deletion, Plasminogen Activator Inhibitor 1, Protein Structure, Tertiary, DNA Primers, DNA, Complementary, COS Cells, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review